Home

Laura A Williams

CIK 1869194 · Chief Patient Officer · last filed 2026-06-22

Laura A Williams is a Chief Patient Officer who has filed 40 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ARDX, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.84M

Companies

2

Total Filings

40

Lifetime Open-Market Net

-$3.30M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX Chief Patient Officer 460,093 $4.00 $1.84M -$3.30M 28 2026-06-22
IMRA Director — $14.59 — $0 2 2022-06-03

Recent Filings

40 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 ARDX Mixed −50,898 -$459.8K EDGAR
2026-06-18 ARDX Notice (144) −81,898 -$478.3K EDGAR
2026-05-22 ARDX Sell (S) −6,989 -$43.8K EDGAR
2026-05-19 ARDX Notice (144) −10,500 -$65.4K EDGAR
2026-02-23 ARDX Sell (S) −8,176 -$47.8K EDGAR
2026-02-20 ARDX Notice (144) −11,300 -$64.7K EDGAR
2026-01-26 ARDX Grant (A) +82,695 $0 EDGAR
2026-01-09 ARDX Mixed — -$299.4K EDGAR
2026-01-08 ARDX Notice (144) −50,000 -$291.5K EDGAR
2025-11-25 ARDX Sell (S) −6,426 -$35.6K EDGAR
Showing 1–10 of 40
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.